Granite Investment Partners, LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1542266
EL SEGUNDO, CA
Position in ADPT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$0
+$0 QoQ
Shares Held
189,304
+51.4% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Granite Investment Partners, LLC holds $47,334,559 across 8 Diagnostics & Research names. ADPT ranks #8 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCYT |
Veracyte, Inc.
|
252,923 | $14,854,167 | |
| 2 | GH |
Guardant Health, Inc.
|
95,760 | $14,366,872 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
11,188 | $5,609,215 | |
| 4 | NEO |
Neogenomics Inc
|
355,141 | $5,181,507 | |
| 5 | DHR |
Danaher Corp /De/
|
25,704 | $4,896,097 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
3,608 | $1,899,395 | |
| 7 | WAT |
Waters Corp /De/
|
1,406 | $527,306 | |
| 8 | ADPT |
Adaptive Biotechnologies Corp
This page
|
189,304 | $0 |
All Filings in ADPT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 757,217 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | — | 500,061 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | — | 10,070 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | — | 10,006 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | — | 11,449 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||